AzTrials
AzTrials

HypertensionNCT02996565

Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure

A study testing Best Practice Clinic-Based Care and Telehealth Care in people with Hypertension, run by HealthPartners Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pragmatic trial will compare two team-based care models for managing hypertension, Best Practice Clinic-based Care and Telehealth Care with pharmacist management, in a large care system in Minnesota. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Hypertension
What is being tested?
Best Practice Clinic-Based Care and Telehealth Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,071 participants
Where
1 siteUnited States
Study dates
15 Nov 2017to 30 Jun 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Hypertension diagnosis code in medical record, twice in last 24 months
  • Attends study clinic for primary care visit within study period with uncontrolled blood pressure
  • Systolic blood pressure >=150 mm Hg or Diastolic blood pressure >=95 mm Hg at current visit
  • Systolic blood pressure >=150 mm Hg or Diastolic blood pressure >=95 mm Hg at most recent previous visit

Who cannot join

  • Pregnancy
  • End Stage Kidney Disease
  • Patients in hospice care and patients who permanently reside in a nursing home

Trial locations and contacts

1 site in 1 country.

United States1 site
  • HealthPartners Institute

    Bloomington, Minnesota, 55425

Other trials in United States

About this study

This pragmatic trial will compare two team-based care models for managing hypertension, Best Practice Clinic-based Care and Telehealth Care with pharmacist management, in a large care system in Minnesota. Clinics in the study are randomized to offer one of the two treatment models to participants with uncontrolled hypertension.

The investigators aim to determine a) whether one model is more effective than the other for lowering patient's blood pressure and b) which model patients prefer.

Read the detailed description

The objectives of the study are:

Aim 1: Compare the effects of two evidence-based strategies on lowering blood pressure and other outcomes important to patients: best-practice clinic-based care and home-based telehealth care.

  • Hypothesis 1.1: Compared with patients in clinics assigned to clinic-based care, patients in clinics assigned to telehealth care will have a 5 mm Hg greater change in systolic blood pressure over 12 months of follow-up.
  • Hypothesis 1.2: Compared with patients in clinics assigned to clinic-based care, patients in clinics assigned to telehealth care will report: a) fewer treatment side effects; b) better ratings of patient experience of hypertension care; and c) higher self-monitoring rates and confidence in self-care.

Aim 2: Conduct an evaluation of the reach, adoption, implementation, and maintenance of the telehealth care and clinic-based care interventions using a mixed-methods approach supported by the RE-AIM framework and the Consolidated Framework for Implementation Research (CFIR).

Conditions
Hypertension
Being tested
Best Practice Clinic-Based Care, Telehealth Care
Keywords
Clinic care, Team-based care, Medication Therapy Management (MTM), Telehealth, Cluster-randomized, Home blood pressure monitoring, Pharmacist
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Best Practice Clinic-Based CareOther

    Relies primarily on the physician-medical assistant dyad and face-to-face visits to promote:

    1. Improved recognition of uncontrolled BP at primary care encounters,
    2. Therapeutic action to address uncontrolled BP at primary care encounters,
    3. Reliable follow-up visits to re-assess uncontrolled BP every 2-4 weeks.
  • Telehealth CareOther

    All elements of Clinic-Based Care are performed, plus a telemonitoring and pharmacist case management program is offered, specifically:

    1. Referral to care by MTM pharmacist or Nurse Practitioner and receiving a home blood pressure telemonitoring device
    2. Systematic home BP telemonitoring with data transmitted into patient medical record
    3. Systematic home-based care by pharmacist or nurse practitioner via telephone and/or secure email
Study groups in NCT02996565
Study groupRoleWhat they receive
Best Practice Clinic-Based CareActive comparatorPatients with uncontrolled hypertension who receive primary care in clinics assigned to the Best Practice Clinic-Based Care intervention.
Receives: Other: Best Practice Clinic-Based Care
Telehealth CareActive comparatorPatients with uncontrolled hypertension who receive primary care in clinics assigned to the Telehealth Care intervention.
Receives: Other: Telehealth Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Systolic Blood Pressure Between Baseline and 12 Months (mm Hg)

    Change in systolic BP, collected from medical records

    Measured: Trajectory over 12 months

Secondary outcomes (29)
  1. Change in Diastolic BP Between Baseline and 12 Months (mm Hg)

    change in diastolic BP, collected from medical records

    Measured: Trajectory over 12 months

  2. Number of Participants Who Reporting Monitoring BP at Least 2 Times Per Week at Six Months Follow-up

    Patient report of monitoring BP at least 2 times per week

    Measured: Baseline to 6 months

  3. Number of Participants Who Report High Level of Satisfaction With Hypertension Care at Six Months.

    Patient rating of 9-10 vs. 0-8 on a scale of 0 (low satisfaction) to 10 (high satisfaction). Developed from a scale used by Green, et al (2008).

    Citation: Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, Carrell D,Tyll L, Larson EB, Thompson RS. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857-2867. doi:10.1001/jama.299.24.2857

    Measured: Baseline to 6 months

  4. Number of Participants Who Are Current Smokers at Twelve Months

    Current smoker at 12 months

    Measured: Baseline to 12 months

  5. Number of Participants Reporting Cough as a Side Effect of Antihypertensive Medications at Six Months

    Patient report that side effect is a problem

    Measured: Baseline to 6 months

  6. Number of Participants Reporting Dizziness as a Side Effect of Antihypertensive Medication at Six Months

    Patient report that side effect is a problem

    Measured: Baseline to 6 months

  7. Number of Participants Reporting Frequent Urination as a Side Effect of Antihypertensive Medication at Six Months

    Patient report that side effect is a problem

    Measured: Baseline to 6 months

  8. Number of Participants Reporting Leg/Foot Swelling as a Side Effect of Antihypertensive Medication at Six Months

    Patient report that side effect is a problem

    Measured: Baseline to 6 months

  9. Number of Participants Reporting Sexual Symptoms as a Side Effect of Antihypertensive Medication at Six Months

    Patient report that side effect is a problem

    Measured: Baseline to 6 months

  10. Number of Participants Reporting Tiredness as a Side Effect of Antihypertensive Medication at Six Months

    Patient report that side effect is a problem

    Measured: Baseline to 6 months

  11. Number of Participants Who Report Decreasing Salt as Helpful for BP Self-management at Six Months

    Patient report that activity is helpful for BP self-management

    Measured: Baseline to 6 months

  12. Number of Participants Who Report Limiting Alcohol as Helpful for BP Self-management at Six Months

    Patient report that activity is helpful for BP self-management

    Measured: Baseline to 6 months

  13. Number of Participants Who Report Physical Activity as Helpful for BP Self-management at Six Months

    Patient report that activity is helpful for BP self management

    Measured: Baseline to 6 months

  14. Number of Participants Who Report Reducing Stress as Helpful for BP Self-management at Six Months

    Patient report that activity is helpful for BP self management

    Measured: Baseline to 6 months

  15. Number of Participants Who Report Watching Weight as Helpful for BP Self-management at Six Months

    Patient report that activity is helpful for BP self management

    Measured: Baseline to 6 months

  16. Number of Participants Identifying Clinic Visits as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  17. Number of Participants Identifying Cost of Care or Medications as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  18. Number of Participants Reporting Increasing Physical Activity as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  19. Number of Participants Reporting Lifestyle Changes as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  20. Number of Participants Reporting Measuring BP as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  21. Number of Participants Reporting Phone Visits as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  22. Number of Participants Reporting Scheduling Visits as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  23. Number of Participants Reporting Time Away From Work as BP Care Burden at Six Months

    Patient report that burden is a problem

    Measured: Baseline to 6 months

  24. Number of Participants Reporting High Confidence in Reporting Contacting Care Team at Six Months Confidence in Managing Blood Pressure: Contact Care Team

    Patient reported "very" or "extremely" confident in this aspect of BP management.

    Measured: Baseline to 6 months

  25. Number of Participants Reporting High Confidence in Keeping BP Below Target at Six Months

    Patient reported "very" or "extremely" confident in this aspect of BP management.

    Measured: Baseline to 6 months

  26. Number of Participants Reporting High Confidence in Knowing BP Target Numbers at Six Months

    Patient reported "very" or "extremely" confident in this aspect of BP management

    Measured: Baseline to 6 months

  27. Number of Participants Reporting High Confidence in Measuring BP at Home at Six Months

    Patient reported "very" or "extremely" confident in this aspect of BP management

    Measured: Baseline to 6 months

  28. Number of Participants Reporting High Confidence in Taking BP Medications at Six Months

    Patient reported "very" or "extremely" confident in this aspect of BP management

    Measured: Baseline to 6 months

  29. Number of Participants With Statin Addition at 12 Months

    New statin medication current at 12 months

    Measured: Baseline to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2016 (estimated)
  2. Study start15 Nov 2017
  3. Primary completion17 Apr 2020
  4. Study completion30 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
3,071 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02996565
Sponsor's protocol ID
HealthPartners Institute
Status last verified
Dec 2020
First submitted
12 Dec 2016
Last updated
23 Sep 2024
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will provide a de-identified, individual-level dataset to PCORI if requested at the end of the study. The dataset will be made publicly available and will contain no identifying information.

Publications

  • Margolis KL, Crain AL, Pawloski PA, Ziegenfuss JY, Trower NK, Bergdall AR, Beran M, Norton CK, Haugen PK, Rehrauer DJ, Green BB, Solberg LI, Sperl-Hillen JM. Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence. J Am Board Fam Med. 2025 Mar-Apr;38(2):312-329. doi: 10.3122/jabfm.2024.240288R1.

    PubMed 40578923
  • Margolis KL, Bergdall AR, Crain AL, JaKa MM, Anderson JP, Solberg LI, Sperl-Hillen J, Beran M, Green BB, Haugen P, Norton CK, Kodet AJ, Sharma R, Appana D, Trower NK, Pawloski PA, Rehrauer DJ, Simmons ML, McKinney ZJ, Kottke TE, Ziegenfuss JY, Williams RA, O'Connor PJ. Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized Trial. Hypertension. 2022 Dec;79(12):2708-2720. doi: 10.1161/HYPERTENSIONAHA.122.19816. Epub 2022 Oct 25.

    PubMed 36281763
  • JaKa M, Bergdall A, Beran MS, Solberg L, Green BB, Andersen J, Kodet A, Norman S, Haugen P, Crain L, Trower N, Sharma R, Rehrauer D, Maeztu C, Margolis K. Reach in a pragmatic hypertension trial: A critical RE-AIM component. Contemp Clin Trials. 2022 Oct;121:106896. doi: 10.1016/j.cct.2022.106896. Epub 2022 Aug 24.

    PubMed 36029952
  • Margolis KL, Crain AL, Green BB, O'Connor PJ, Solberg LI, Beran M, Bergdall AR, Pawloski PA, Ziegenfuss JY, JaKa MM, Appana D, Sharma R, Kodet AJ, Trower NK, Rehrauer DJ, McKinney Z, Norton CK, Haugen P, Anderson JP, Crabtree BF, Norman SK, Sperl-Hillen JM. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence. Trials. 2022 Aug 17;23(1):673. doi: 10.1186/s13063-022-06611-3.

    PubMed 35978336
  • Solberg LI, Crain AL, Green BB, Ziegenfuss JY, Beran MS, Sperl-Hillen JM, Norton CK, Margolis KL. Experiences and Perceptions of Patients with Uncontrolled Hypertension Who are Dissatisfied with Their Hypertension Care. J Am Board Fam Med. 2021 Nov-Dec;34(6):1115-1122. doi: 10.3122/jabfm.2021.06.210240.

    PubMed 34772767
  • Margolis KL, Crain AL, Bergdall AR, Beran M, Anderson JP, Solberg LI, O'Connor PJ, Sperl-Hillen JM, Pawloski PA, Ziegenfuss JY, Rehrauer D, Norton C, Haugen P, Green BB, McKinney Z, Kodet A, Appana D, Sharma R, Trower NK, Williams R, Crabtree BF. Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. Contemp Clin Trials. 2020 May;92:105939. doi: 10.1016/j.cct.2020.105939. Epub 2020 Jan 22.

    PubMed 31981712

Questions about this trial

What is this clinical trial studying?

A study testing Best Practice Clinic-Based Care and Telehealth Care in people with Hypertension, run by HealthPartners Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Sep 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Systolic Blood Pressure Between Baseline and 12 Months (mm Hg) (time frame: Trajectory over 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02996565, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2024; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in